. In MONARCH 0, for patients receiving Verzenio plus an aromatase inhibitor with Grade ≥0 increases in ALT or AST, median time to onset was 00 and 00 days, respectively, and median time to resolution to Grade <0 was 00 and 00 days, respectively. In MONARCH 0, for patients receiving Verzenio plus 